[Resistance to imipenem in Enterobacter aerogenes]. 1995

E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
Servicio de Microbiología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma, Barcelona.

BACKGROUND In June, 1993, an Enterobacter aerogenes strain was isolated in the Hospital de la Creu Roja from Hospitalet de Llobregat (Barcelona), which was resistant against all beta-lactams, including imipenem. Since is unusual in Enterobacter sp. to isolate imipenem resistant strains, we decided to study its resistance mechanism. METHODS To study the E. aerogenes 174004/H resistance mechanism beta-lactamase isoelectrofocalization was performed together with the determination of kinetic constants in order to characterize the beta-lactamase, and a polyacrylamide gel electrophoresis in order to observe the profile. RESULTS The strain of E. aerogenes 174004/H exhibits a chromosomic beta-lactamase with a pI higher than 9.2 and a decrease in an outer membrane protein of 42 kDa, probably a porine. CONCLUSIONS E. aerogenes 174004/H resistance against imipenem is due to an hyperproduction of a chromosomic beta-lactamase with a pI higher than 9.2 and to a 42 kDa decrease of an outer membrane protein expression.

UI MeSH Term Description Entries
D004754 Enterobacter Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D015378 Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Imipemide,N-Formimidoylthienamycin,Imipenem Anhydrous,Imipenem, Anhydrous,MK-0787,MK0787,Anhydrous Imipenem,Anhydrous, Imipenem,MK 0787,N Formimidoylthienamycin
D018440 beta-Lactam Resistance Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets. beta-Lactam Resistant,beta-Lactamase Resistance,beta-Lactamase Resistant,Resistance, beta-Lactamase,Resistant, beta-Lactamase,beta Lactam Resistance,beta Lactam Resistant,beta Lactamase Resistance,beta Lactamase Resistant

Related Publications

E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
March 2000, Journal of clinical microbiology,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
January 1990, The Journal of antimicrobial chemotherapy,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
May 2004, Biochemical and biophysical research communications,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
August 1993, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
February 2003, Biochemical and biophysical research communications,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
August 1992, FEMS microbiology letters,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
June 1994, Journal of medical microbiology,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
October 1991, The Journal of antimicrobial chemotherapy,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
January 2015, PloS one,
E Miró, and C Alonso, and F Navarro, and B Mirelis, and G Prats
January 1993, Journal of clinical microbiology,
Copied contents to your clipboard!